[New] VYEPTI for Migraine Prevention App... - My MSAA Community

My MSAA Community

9,079 members20,826 posts

[New] VYEPTI for Migraine Prevention Approved by FDA

bxrmom profile image
3 Replies

Vyepti is the first anti-CGRP drug to be administered in a quarterly intravenous infusion. Other drugs in this category – Aimovig, Emgality, and Ajovy – are given monthly via injection.

For more information: migraineagain.com/new-vyept...

Written by
bxrmom profile image
bxrmom
To view profiles and participate in discussions please or .
Read more about...
3 Replies
jimeka profile image
jimeka

Thank you for the link, I have forwarded to my daughter, Blessings Jimeka 🤗

bxrmom profile image
bxrmom in reply to jimeka

You are most welcome! They are coming out with so many different medications for migraines lately. Some are either pill, injections, or infusions.

laddy3 profile image
laddy3

Yes thank you for the info but unless you are covered by private insurance this will not be affordable sadly to a lot of people 🙈 I actually participated in the trials 2014 for Botox and was refused by my doctor even though I take Chronic migraines which I live with daily so not much chance of getting any of this 🙈

You may also like...

Glatopa: FDA Approves Three-Times Weekly Dose

States Food and Drug Administration (FDA) approved Glatopa® (glatiramer acetate injection) at a...

New Shingles vaccine FDA approved

Ocrevus: FDA Approves First Drug to Treat Two Forms of MS

monoclonal antibody and is given via intravenous (IV) infusion every six months. It has been shown...

Blood Test for MS Activity Gets FDA Breakthrough Designation

The US Food and Drug Administration (FDA) has granted breakthrough device designation to the...

Approvals for Medicine

Ocrevus? How long did it take for your first infusion to be approved? My son was diagnosed on Dec...